Ask AI

Expert Think Tank: From Evidence to Practice—Navigating Controversies in Bridging Therapy in Myeloma CAR-T Treatment

Gain expert insights into the role and benefits of bridging therapy prior to CAR T-cell treatment in patients with multiple myeloma to optimize outcomes through a ClinicalThought commentary, certified text modules, and accompanying downloadable slides.

Share

Program Content

Activities

CAR T Bridging in MM
Optimizing Bridging Therapy: Selection and Timing to Support CAR T-Cell Success in MM
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2025

Expires: April 29, 2026

Activities

Selecting Bridging Therapy
Optimizing Bridging Therapy: Selection and Timing to Support CAR T-Cell Success in MM
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson